Maggie^® is an easy-to-use, cartridge-based autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT^®). Requiring just two simple steps to operate, Maggie^® opens  up pathways for larger fill  volumes and an enhanced  injection experience.

Feb 5-6 Paris, France

Booth C64

Learn more at 2020 Pharmapack Europe

Maggie^®

Transform your cartridge-based treatment with Maggie^®, a two-step autoinjector built with SHL’s proprietary Needle Isolation Technology (NIT^®).

NIT^® is a unique safety solution that makes it possible for cartridges to function like traditional pre-filled syringes with staked needles. Cartridges support higher volume dosing and enable dual-chamber treatments to be built as easy-to-use autoinjectors.

Maggie^® is built with a 3mL standard ISO cartridge to support the growing trend for high-volume dosing with the emergence of biologics and biosimilars. Cartridges also offer a level of needle customization for subcutaneous or intramuscular injections.

Maggie^®’s NIT^® sub-assembly includes a pre-attached needle. Users simply untwist the cap to attach the needle and open the fluid path. The needle cover automatically extends and the autoinjector automatically primes.

Injection with Maggie^® is completed with just two simple steps: uncap and inject. The autoinjector needle cover locks out after injection, shielding patients from being exposed to the needle before and after injection.

Maggie^®’s large viewing window makes it easier for patients to inspect the drug before and during injection. It also features continuous audible clicks during injection, resulting in an easier determination of dose completion.

www.shl.group

info@shl-group.com